REG - Barclays PLC Primary Health Props - Form 8.5 EPT/Non RI PRIMARY HEALTH PROPERTIES PLC
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250724:nRSX4522Sa&default-theme=true
RNS Number : 4522S Barclays PLC 24 July 2025
FORM 8.5 (EPT/NON-RI)
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS
(OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: BARCLAYS CAPITAL SECURITIES LTD
(b) Name of offeror/offeree in relation to whose PRIMARY HEALTH PROPERTIES PLC
relevant securities this form relates:
(c) Name of the party to the offer with which exempt ASSURA PLC
principal trader is connected
(d) Date position held/dealing undertaken: 23 Jul 2025
(e) In addition to the company in 1(b) above, is the exempt principal YES:
trader making disclosures in respect of any other party to the offer? ASSURA PLC
2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER
(a) Interests and short positions in the relevant securities of the offeror or
offeree
to which the disclosure relates following the dealing (if any)
Class of relevant security: 12.5p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 18,342,274 1.37% 8,979,203 0.67%
(2) Cash-settled derivatives:
and/or controlled: 7,767,535 0.58% 17,576,348 1.32%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 26,109,809 1.95% 26,555,551 1.99%
(b) Rights to subscribe for new securities (including directors and other
executive
options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a) Purchases and sales
Class of relevant Purchase/sale Total number of Highest price per unit Lowest price per unit
security securities paid/received paid/received
12.5p ordinary Purchase 2,139,496 0.9665 GBP 0.9560 GBP
12.5p ordinary Sale 1,181,301 0.9650 GBP 0.9560 GBP
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
12.5p ordinary SWAP Decreasing Short 1,769 0.9560 GBP
12.5p ordinary SWAP Decreasing Short 147 0.9561 GBP
12.5p ordinary SWAP Decreasing Short 23,697 0.9609 GBP
12.5p ordinary SWAP Decreasing Short 27,705 0.9616 GBP
12.5p ordinary SWAP Decreasing Short 2 0.9620 GBP
12.5p ordinary SWAP Decreasing Short 34,286 0.9626 GBP
12.5p ordinary SWAP Decreasing Short 97,152 0.9627 GBP
12.5p ordinary SWAP Decreasing Short 72,989 0.9628 GBP
12.5p ordinary SWAP Decreasing Short 14,079 0.9633 GBP
12.5p ordinary SWAP Decreasing Short 9,430 0.9636 GBP
12.5p ordinary SWAP Decreasing Short 2,670 0.9650 GBP
12.5p ordinary SWAP Decreasing Short 531 0.9690 GBP
12.5p ordinary SWAP Decreasing Short 548 22.8224 ZAR
12.5p ordinary SWAP Increasing Short 495,054 0.9560 GBP
12.5p ordinary SWAP Increasing Short 697,594 0.9612 GBP
12.5p ordinary SWAP Increasing Short 615 0.9620 GBP
12.5p ordinary SWAP Increasing Short 11,396 0.9630 GBP
12.5p ordinary SWAP Increasing Short 11,050 0.9636 GBP
12.5p ordinary SWAP Increasing Short 1,809 0.9652 GBP
12.5p ordinary SWAP Increasing Short 3,892 0.9665 GBP
12.5p ordinary SWAP Increasing Short 139 22.8236 ZAR
12.5p ordinary SWAP Increasing Short 200 23.2460 ZAR
12.5p ordinary CFD Decreasing Short 548 0.9614 GBP
12.5p ordinary CFD Decreasing Short 99,626 0.9630 GBP
12.5p ordinary CFD Decreasing Short 139 22.8212 ZAR
12.5p ordinary CFD Decreasing Short 200 23.2430 ZAR
12.5p ordinary CFD Increasing Short 112,323 0.9560 GBP
12.5p ordinary CFD Increasing Short 15,935 0.9614 GBP
12.5p ordinary CFD Increasing Short 614 0.9620 GBP
12.5p ordinary CFD Increasing Short 548 22.8254 ZAR
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying etc to which received
option per unit
relates
(ii) Exercising
Class of relevant Product description Exercising/ exercised against Number of Exercise price per
security securities unit
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of Dealings Details Price per unit (if
security applicable)
4. OTHER INFORMATION
(a) Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding,
formal or informal, relating to relevant securities which may be an inducement
to deal
or refrain from dealing entered into by the exempt principal trader making the
disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between
the exempt principal trader making the disclosure and any other person
relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant
securities to which
any derivative is referenced:
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 24 Jul 2025
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FEOUSVRRVAUBUARRecent news on Primary Health Properties
See all newsREG - Primary Health Props - Director Appointment
AnnouncementREG - Primary Health Props - Director/PDMR Shareholding
AnnouncementREG - Competition and Mkts - Merger Update: Primary Health Properties/Assura
AnnouncementREG - Competition and Mkts - Merger Update: PHP/Assura
AnnouncementREG - Primary Health Props Assura PLC - Acquisition of Assura plc – CMA Phase 1 Clearance
Announcement